MedPath

VYEPTI

VYEPTI

Approved
DIN Number

02542269

Drug Class

Human

Market Date

Jul 1, 2024

Company
HC

Lundbeck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02542269
AIG Number0162703001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
N02CD05 EPTINEZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification28:32.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

EPTINEZUMABActive
Strength: 300 MG / 3 ML
Monograph: EPTINEZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.